{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:31:22Z","timestamp":1757626282627,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01891-6","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:13:57Z","timestamp":1755058437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms and clinical translation of ICOS\/ICOSL signaling pathway blockade in delaying vascular complications of type 2 diabetes"],"prefix":"10.1186","volume":"17","author":[{"given":"Haiyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiBo","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17).","DOI":"10.3390\/ijms21176275"},{"key":"1891_CR2","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.metop.2024.100287","volume":"22","author":"S Singh","year":"2024","unstructured":"Singh S, Kriti M, K SA, Sarma DK, Verma V, Nagpal R, et al. Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review. Metabol Open. 2024;22:100287.","journal-title":"Metabol Open"},{"issue":"6","key":"1891_CR3","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/dom.15511","volume":"26","author":"SK Kunutsor","year":"2024","unstructured":"Kunutsor SK, Balasubramanian VG, Zaccardi F, Gillies CL, Aroda VR, Seidu S, et al. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes. Diabetes Obes Metab. 2024;26(6):2069\u201381.","journal-title":"Diabetes Obes Metab"},{"key":"1891_CR4","doi-asserted-by":"publisher","first-page":"1143067","DOI":"10.3389\/fendo.2023.1143067","volume":"14","author":"A Mansour","year":"2023","unstructured":"Mansour A, Mousa M, Abdelmannan D, Tay G, Hassoun A, Alsafar H. Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome-wide association analyses. Front Endocrinol (Lausanne). 2023;14:1143067.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1891_CR5","doi-asserted-by":"publisher","first-page":"1359255","DOI":"10.3389\/fendo.2024.1359255","volume":"15","author":"DR Yang","year":"2024","unstructured":"Yang DR, Wang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne). 2024;15:1359255.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1891_CR6","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.3390\/cimb45080420","volume":"45","author":"A Caturano","year":"2023","unstructured":"Caturano A, D\u2019Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023;45(8):6651\u201366.","journal-title":"Curr Issues Mol Biol"},{"key":"1891_CR7","doi-asserted-by":"crossref","unstructured":"Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Di Lorenzo G et al. Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications. Antioxid (Basel). 2025;14(1).","DOI":"10.3390\/antiox14010072"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"1072288","DOI":"10.3389\/fendo.2023.1072288","volume":"14","author":"K Siddiqui","year":"2023","unstructured":"Siddiqui K, George TP, Mujammami M, Isnani A, Alfadda AA. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study. Front Endocrinol (Lausanne). 2023;14:1072288.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1891_CR9","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh V, Kaur R, Kumari P, Pasricha C, Singh R. ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta. 2023;548:117487.","journal-title":"Clin Chim Acta"},{"issue":"45","key":"1891_CR10","doi-asserted-by":"publisher","first-page":"e31667","DOI":"10.1097\/MD.0000000000031667","volume":"101","author":"M Yang","year":"2022","unstructured":"Yang M, Tian S, Lin Z, Fu Z, Li C. Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review. Med (Baltim). 2022;101(45):e31667.","journal-title":"Med (Baltim)"},{"key":"1891_CR11","doi-asserted-by":"crossref","unstructured":"Solinas C, Gu-Trantien C, Willard-Gallo K. The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy. ESMO Open. 2020;5(1).","DOI":"10.1136\/esmoopen-2019-000544"},{"key":"1891_CR12","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.bbadva.2023.100103","volume":"4","author":"L Lu","year":"2023","unstructured":"Lu L, Jin Y, Tong Y, Xiao L, Hou Y, Liu Z, et al. Myeloid-derived suppressor cells promote the formation of abdominal aortic aneurysms through the IL-3-ICOSL-ICOS axis. BBA Adv. 2023;4:100103.","journal-title":"BBA Adv"},{"issue":"24","key":"1891_CR13","first-page":"8898","volume":"22","author":"HY Zhang","year":"2018","unstructured":"Zhang HY, Ruan LB, Li Y, Yang TR, Liu WJ, Jiang YX, et al. ICOS\/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2018;22(24):8898\u2013908.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1891_CR14","doi-asserted-by":"publisher","first-page":"992614","DOI":"10.3389\/fimmu.2022.992614","volume":"13","author":"GF Alves","year":"2022","unstructured":"Alves GF, Stoppa I, Aimaretti E, Monge C, Mastrocola R, Porchietto E, et al. ICOS-Fc as an innovative Immunomodulatory approach to counteract inflammation and organ injury in sepsis. Front Immunol. 2022;13:992614.","journal-title":"Front Immunol"},{"key":"1891_CR15","doi-asserted-by":"crossref","unstructured":"Banche-Niclot F, Corvaglia I, Cavalera C, Boggio E, Gigliotti CL, Dianzani U et al. Optimization of an injectable, resorbable, bioactive cement able to release the Anti-Osteoclastogenic biomolecule ICOS-Fc for the treatment of osteoporotic vertebral compression fractures. Biomolecules. 2023;13(1).","DOI":"10.3390\/biom13010094"},{"issue":"1","key":"1891_CR16","doi-asserted-by":"publisher","first-page":"15348","DOI":"10.1038\/s41598-024-65188-w","volume":"14","author":"S Zaib","year":"2024","unstructured":"Zaib S, Ahmad S, Khan I, Bin Jardan YA, Fentahun Wondmie G. An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus. Sci Rep. 2024;14(1):15348.","journal-title":"Sci Rep"},{"issue":"1","key":"1891_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12933-021-01267-w","volume":"20","author":"A Giannella","year":"2021","unstructured":"Giannella A, Ceolotto G, Radu CM, Cattelan A, Iori E, Benetti A, et al. PAR-4\/Ca(2+)-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):77.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1891_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13813455.2018.1538248","volume":"126","author":"R Fadaei","year":"2020","unstructured":"Fadaei R, Dadmanesh M, Moradi N, Ahmadi R, Shokoohi Nahrkhalaji A, Aghajani H, et al. Serum levels of subfatin in patients with type 2 diabetes mellitus and its association with vascular adhesion molecules. Arch Physiol Biochem. 2020;126(4):335\u201340.","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"1891_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-022-01457-0","volume":"21","author":"M You","year":"2022","unstructured":"You M, Liu Y, Wang B, Li L, Zhang H, He H, et al. Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease. Cardiovasc Diabetol. 2022;21(1):25.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"1891_CR20","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1111\/jcmm.16543","volume":"25","author":"LM Makowski","year":"2021","unstructured":"Makowski LM, Leffers M, Waltenberger J, Pardali E. Transforming growth factor-\u03b21 signalling triggers vascular endothelial growth factor resistance and monocyte dysfunction in type 2 diabetes mellitus. J Cell Mol Med. 2021;25(11):5316\u201325.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1891_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imcb.12520","volume":"100","author":"M Dong","year":"2022","unstructured":"Dong M, Chang J, Lebel M, Gervais N, Fournier M, Mallet Gauthier \u00c8, et al. The ICOS-ICOSL pathway tunes thymic selection. Immunol Cell Biol. 2022;100(3):205\u201317.","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"1891_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/stem.3369","volume":"39","author":"X Fan","year":"2021","unstructured":"Fan X, Xu ZB, Li CL, Zhang HY, Peng YQ, He BX, et al. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction. Stem Cells. 2021;39(7):975\u201387.","journal-title":"Stem Cells"},{"issue":"5","key":"1891_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00011-023-01731-1","volume":"72","author":"X Cabana-Puig","year":"2023","unstructured":"Cabana-Puig X, Lu R, Geng S, Michaelis JS, Oakes V, Armstrong C, et al. CX(3)CR1 modulates SLE-associated glomerulonephritis and cardiovascular disease in mrl\/lpr mice. Inflamm Res. 2023;72(5):1083\u201397.","journal-title":"Inflamm Res"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01891-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01891-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01891-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:22:39Z","timestamp":1757452959000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01891-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01891-6","relation":{},"ISSN":["1758-5996"],"issn-type":[{"type":"electronic","value":"1758-5996"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the First People\u2019s Hospital of Yunnan Province for human participants and the Institutional Animal Care and Use Committee (IACUC) of Yunnan First People\u2019s Hospital for animal experiments. Written informed consent was obtained from all human participants, who were fully informed about the study\u2019s purpose, voluntary participation, and right to withdraw at any time. Animal procedures adhered to ethical guidelines to minimize suffering, and humane euthanasia was performed as required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the manuscript for publication. Written informed consent was obtained from the participants for the publication of their data, including any personal information that might be included in the study findings. The consent covers the publication of anonymized results and data in scientific journals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}